Clinical Trial Update: A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating ABT-888 (veliparib) in combination with whole-brain radiation therapy for patients with brain metastases has completed. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Brain Neoplasms

Drugs mentioned

• ABT-888 (veliparib)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Brain Diseases, Brain Neoplasms | Phase 1 | Status: COMPLETED